Metabolic changes and excess circulating glucose in pregnant women with gestational diabetes and urinary incontinence can lead to serious complications since pregnant women present changes in serotonin and IL-10 cytokine levels, as well as in hematological and rheological parameters, and monitoring and controlling glucose levels are crucial to preventing adverse outcomes. This evidence concerns the gene IL10 and Urinary incontinence.